Biotech

All Articles

Basilea ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work establishing brand-new antifungals has actually gotten a considerable ...

Capricor offers Europe rights to late-stage DMD therapy for $35M

.Having currently gathered up the USA civil rights to Capricor Therapeutics' late-stage Duchenne mus...

FDA fragments adcomm for Applied's unusual condition medicine

.After pushing the decision date for Applied Rehabs' metabolic condition medicine govorestat, the FD...

Novo inks $600M NanoVation bargain to research hereditary drugs ex-liver

.Novo Nordisk is proceeding its press right into hereditary medicines, accepting compensate NanoVati...

Innovent hyperlinks cytokine to intestines cancer actions

.Innovent Biologics has made the instance that its gate inhibitor-cytokine fusion healthy protein ha...

Merck, Daiichi ADC attacks target in period 3 lung cancer cells research study

.A period 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina deepens AI concentrate with collab to select cancer intendeds

.Five months after Rakovina Rehabs turned towards artificial intelligence, the cancer-focused biotec...

Ascendis' dwarfism drug hits in phase 3, endangers BioMarin

.Ascendis Pharma has actually emerged as a prospective threat to BioMarin's Voxzogo, stating phase 3...

Despite ph. 3 overlook, Alkeus views pathway in advance for eye disease resource

.Though Alkeus Pharmaceuticals' oral eye health condition property neglected to substantially lessen...

Kairos goes social with $6M IPO to money trials of cancer cells medication

.With a triad of biotechs reaching the Nasdaq on Friday, it was quick and easy to overlook a smaller...